Author:
Nizioł Joanna,Ossoliński Krzysztof,Płaza-Altamer Aneta,Kołodziej Artur,Ossolińska Anna,Ossoliński Tadeusz,Nieczaj Anna,Ruman Tomasz
Abstract
AbstractBladder cancer (BC) is a common urological malignancy with a high probability of death and recurrence. Cystoscopy is used as a routine examination for diagnosis and following patient monitoring for recurrence. Repeated costly and intrusive treatments may discourage patients from having frequent follow-up screenings. Hence, exploring novel non-invasive ways to help identify recurrent and/or primary BC is critical. In this work, 200 human urine samples were profiled using ultra-high-performance liquid chromatography and ultra-high-resolution mass spectrometry (UHPLC-UHRMS) to uncover molecular markers differentiating BC from non-cancer controls (NCs). Univariate and multivariate statistical analyses with external validation identified metabolites that distinguish BC patients from NCs disease. More detailed divisions for the stage, grade, age, and gender are also discussed. Findings indicate that monitoring urine metabolites may provide a non-invasive and more straightforward diagnostic method for identifying BC and treating recurrent diseases.
Publisher
Springer Science and Business Media LLC
Reference67 articles.
1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424 (2018).
2. Li, M. et al. Recent progress in biosensors for detection of tumor biomarkers. Molecules 27, 7327 (2022).
3. Steinestel, K. et al. Detection of urinary molecular marker test in urothelial cell carcinoma: A review of methods and accuracy. Diagnostics 12, 2696 (2022).
4. Di Meo, N. A. et al. Metabolomic approaches for detection and identification of biomarkers and altered pathways in bladder cancer. Int. J. Mol. Sci. 23, 4173 (2022).
5. Ng, K., Stenzl, A., Sharma, A. & Vasdev, N. Urinary biomarkers in bladder cancer: A review of the current landscape and future directions. Urol. Oncol. Semin. Orig. Investig. 39, 41–51 (2021).
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献